RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 92 filers reported holding RUBIUS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $2,294,000 | -43.1% | 416,396 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $4,031,000 | -45.9% | 416,396 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $7,445,000 | -26.8% | 416,396 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $10,164,000 | -7.9% | 416,396 | 0.0% | 0.00% | -33.3% |
| Q1 2021 | $11,034,000 | +249.2% | 416,396 | 0.0% | 0.00% | +200.0% |
| Q4 2020 | $3,160,000 | +51.5% | 416,396 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $2,086,000 | -16.2% | 416,396 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $2,490,000 | +34.4% | 416,396 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $1,853,000 | -53.2% | 416,396 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $3,956,000 | +21.0% | 416,396 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $3,269,000 | -50.1% | 416,396 | 0.0% | 0.00% | -66.7% |
| Q2 2019 | $6,550,000 | -13.1% | 416,396 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $7,537,000 | +23.7% | 416,396 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $6,093,000 | -51.4% | 416,396 | -29.0% | 0.00% | -50.0% |
| Q3 2018 | $12,525,000 | – | 586,396 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |